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Abstract As a step in their turnover proteins in eukaryotic
cells are coupled to a small protein, ubiquitin, before they are
recognised by 26S proteasomes and degraded. However, cells
also contain many deubiquitinating enzymes, which can rescue
proteins by cleaving o¡ the ubiquitin chains. Here we report that
three ubiquitin binding proteins, Rhp23, Dph1 and Pus1, from
¢ssion yeast can protect multiubiquitin conjugates against de-
ubiquitination. This protection depends on the ubiquitin binding
domains and may promote degradation of ubiquitinated pro-
teins.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Protein degradation in eukaryotic cells is important for
many regulatory mechanisms [1]. Before they are degraded,
proteins are marked for destruction by being furnished with a
chain of ubiquitin. The multiubiquitin gives them a⁄nity for
the 26S proteasome, a multisubunit protease responsible for
degradation of most cell proteins [1].
Ubiquitin ligation is accomplished in multiple steps. Ini-
tially the E1 enzyme activates ubiquitin in an ATP-consuming
process. Ubiquitin is then transferred to an E2 enzyme and
¢nally to the target protein in a process catalysed by an E3
enzyme [2]. Several rounds of conjugation yield substrates
carrying chains of ubiquitin moieties. A range of di¡erent
E2s and E3s confer substrate speci¢city to the process.
The 26S proteasome consists of a proteolytically active 20S
cylinder with 19S regulatory ATPase complexes attached to
the ends [3,4]. The 19S complexes regulate the access to the
proteolytic cylinder [4] and recognise substrates [5,6] which
usually must be conjugated to a chain of at least four ubiq-
uitin moieties [7].
Several deubiquitinating enzymes appear to play important
regulatory roles in trimming the length of ubiquitin chains on
target proteins [8]. Ubiquitination therefore re£ects the bal-
ance between multiubiquitination and either degradation of
conjugates by the 26S proteasome or disassembly of the ubiq-
uitin chains by deubiquitinating enzymes. Hence, deubiquiti-
nation of a substrate may render it unrecognisable to the 26S
proteasome and rescue it from degradation.
A number of ubiquitin binding proteins have been de-
scribed [9,10] and the protein domains involved in ubiquitin
binding have been characterised [11^13]. One of these proteins
is the subunit of the 26S proteasome called S5a in mammals
[9] and Rpn10 or Pus1 in budding and ¢ssion yeast, respec-
tively [14,15]. It binds ubiquitin chains via a ubiquitin inter-
action motif (UIM) [11] and appears to work as a substrate
binding site for the 26S proteasome [5,9,10]. In yeast [14,15],
but not in mammals [16], S5a/Rpn10/Pus1 is found as a free
protein, besides being incorporated into the 26S proteasome.
The proteasome interacting proteins called Rad23 and
Dsk2 in budding yeast and Rhp23 and Dph1 in ¢ssion yeast
also bind multiubiquitin. Rad23/Rhp23 and Dsk2/Dph1 uti-
lise a ubiquitin pathway-associated (UBA) domain for ubiq-
uitin binding [10]. Like the UIM domain, the UBA domain
preferably binds chains composed of at least four ubiquitin
moieties and both Rad23/Rhp23 and Dsk2/Dph1 appear to
target substrates to the 26S protease [10,17^19].
Here we report that in the ¢ssion yeast Schizosaccharomyces
pombe, Rhp23 and Dph1 protect ubiquitin chains against dis-
assembly by deubiquitinating enzymes. Pus1 also protects
against deubiquitination, but much less e⁄ciently. This inhi-
bition of deubiquitination depends on the ubiquitin binding
domains and is the ¢rst example of naturally occurring pro-
tectors of multiubiquitin chains.
2. Materials and methods
2.1. Protein expression and puri¢cation
The expression plasmids were: ubiquitin-speci¢c protease Y
(UBPY) [20], Rhp23, Rhp23UBA1, Rhp23UBA2, Rhp23PP, Dph1,
Pus1, Pus1UIM and Pus1N5 [10,15], all subcloned into the pGEX-
KG vector (Amersham-Pharmacia).
Glutathione S-transferase (GST) fusion proteins were expressed in
Escherichia coli BL21 (DE3) pLysS, bound to glutathione Sepharose 4
beads (Amersham-Pharmacia) and released with thrombin (Amer-
sham-Pharmacia) as described by the manufacturer. Protein concen-
trations were determined [21] with bovine serum albumin as a stan-
dard.
2.2. UBPY binding experiments
Approximately 10 Wg of GST or GST-tagged UBPY on glutathione
Sepharose 4 beads was incubated overnight at 4‡C in bu¡er A (50
mM Tris^HCl pH 7.5, 100 mM NaCl, 10% glycerol, 1% Triton X-100,
2 mM EDTA, 2 mM dithiothreitol (DTT) and 1 mM phenylmethyl-
sulphonyl £uoride (PMSF)) with 1 Wg of puri¢ed Rhp23, Dph1 or
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Pus1. The beads were washed in bu¡er A, bound proteins separated
on 12.5% sodium dodecyl sulphate (SDS) gels and analysed by West-
ern blotting with rabbit antisera against Rhp23, Dph1 and Pus1 (not
shown).
2.3. Deubiquitination assays
Aliquots of 1 Wg K48-conjugated tetraubiquitin chains (A⁄niti Re-
search Products) were incubated overnight at 37‡C with 1 Wg of
UBPY in 30 Wl bu¡er B (50 mM Tris^HCl pH 8.3, 5 mM MgCl2,
2 mM DTT and 2 mM NaN3) containing ubiquitin binding proteins
or ubiquitin aldehyde (Ubal) (A⁄niti Research Products) at a con-
centration of 5 WM.
Degradation products were analysed by SDS^polyacrylamide gel
electrophoresis (PAGE) and Western blotting with rabbit anti-ubiq-
uitin antibody. A mixture of mono-, di-, tri-, tetra-, penta-, hexa- and
heptaubiquitin (Ub17) (A⁄niti Research Products) was used as a
marker.
For ubiquitin-7-amino-4-methylcoumarin (ubiquitin-AMC) (A⁄niti
Research Products) deubiquitination assays, samples were incubated
for 30 min at 37‡C in 200 Wl of 0.5 WM ubiquitin-AMC, 50 mM Tris^
HCl pH 8.0, 5 mM DTT and 0.1% Tween-20. After addition of 100 Wl
10% SDS and 1.5 ml 0.1 M sodium borate pH 9.1, the £uorescence
was determined at an excitation wavelength of 380 nm and an emis-
sion of 460 nm. Less than 5% of the substrate was cleaved during the
incubation (not shown).
For deubiquitination assays in cell extracts the temperature sensi-
tive S. pombe proteasome mutant mts3-1 [22] strain was grown at
28‡C to mid-exponential phase in YPD. The cells were then incubated
for another 24 h at 35‡C and lysed using glass beads in ice cold bu¡er
C (50 mM Tris^HCl pH 7.5, 100 mM NaCl, 10% glycerol, 2 mM
DTT, 1 mM PMSF, EDTA-free Complete1 protease inhibitors
(Roche) and 50 WM of the proteasome inhibitor Z-Ile-Glu(OtBu)-
Ala-Leu-aldehyde (Bachem)). To 50 Wl cell extract (1 mg protein/ml)
2 Wg of either Rhp23, Dph1 or Pus1 in bu¡er C was added. After 3 h
at 37‡C, proteins were separated by SDS^PAGE and analysed by
Western blotting with rabbit anti-ubiquitin antibody.
3. Results
Overexpression of Rhp23 and Dph1 causes a dramatic in-
crease in the level of ubiquitinated proteins in vivo [17,23^26].
This e¡ect might be due to an inhibition of either the 26S
Fig. 1. Protection of tetraubiquitin chains. Deubiquitination of tet-
raubiquitin by UBPY without addition (lane 3) or in the presence
of the ubiquitin binding proteins Rhp23 (lane 4), Dph1 (lane 5),
Pus1 (lane 6) or the inhibitor Ubal (lane 7). The degradation prod-
ucts were analysed by SDS^PAGE and Western blotting with an
anti-ubiquitin antibody. Tetraubiquitin chains without UBPY were
not disassembled (lane 2). For comparison a mixture of mono-
(Ub), di- (Ub2), tri- (Ub3), tetra- (Ub4), penta- (Ub5), hexa- (Ub6)
and heptaubiquitin (Ub7) was loaded (lane 1).
A
B
Fig. 2. Inhibition is dependent on ubiquitin binding. A: Deubiquiti-
nation by UBPY of tetraubiquitin chains (lane 2) was performed in
the presence of the ubiquitin binding proteins Rhp23 (lane 3) or
Pus1 (lane 7). No inhibition of deubiquitination is seen with
Rhp23PP (lane 4) or Pus1N5 (lane 8) which carry point mutations
abrogating ubiquitin binding in the UBA and UIM domains respec-
tively. Alone the two UBA domains of Rhp23 (Rhp23UBA1 and
Rhp23UBA2) (lanes 5 and 6) or the UIM domain of Pus1 (Pus1-
UIM) (lane 9) inhibit deubiquitination as e⁄ciently as the full
length proteins (lanes 3 and 7). Tetraubiquitin chains without
UBPY were not disassembled (lane 1). B: The domain organisation
of the various expression constructs is shown in a schematised form
(not to scale). These proteins have previously been assayed for bind-
ing to multiubiquitin chains [10,15].
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proteasome or the deubiquitinating enzymes (DUBs) or
both.
To investigate the e¡ect of ubiquitin binding proteins on
deubiquitination in vitro we set up a deubiquitination assay
using human UBPY [20] and tetraubiquitin chains conjugated
through lysine 48. UBPY disassembled tetraubiquitin chains
(Fig. 1, lanes 2 and 3) and was e⁄ciently inhibited by the
speci¢c DUB inhibitor Ubal (Fig. 1, lane 7). However, when
added in equimolar amounts with the substrate, Rhp23, Dph1
and less so Pus1 inhibited deubiquitination (Fig. 1, lanes 4^6).
Next we wished to determine whether the inhibitory e¡ects
of Rhp23, Dph1 and Pus1 on deubiquitination depend on
their multiubiquitin binding. Certain point mutants in the
ubiquitin binding sites of Rhp23 and Pus1 are unable to in-
teract with ubiquitin chains [10,15]. Using these mutant pro-
teins we now show that ubiquitin binding is essential for the
proteins’ ability to inhibit deubiquitination (Fig. 2). In the
Rhp23PP mutant, where a conserved glycine residue in each
of the UBA domains has been mutated to proline [10], the
inhibition of UBPY-mediated chain disassembly was abro-
gated (Fig. 2A, lane 4). Similarly, when we used a Pus1N5
mutant, where the conserved LALAL motif in the UIM do-
main has been changed to ¢ve consecutive asparagine residues
[15], the inhibitory e¡ect was also no longer visible (Fig. 2A,
lane 8).
Moreover, using truncated versions of Rhp23 and Pus1
which encode the ubiquitin binding domains alone (Rhp23U-
BA1, Rhp23UBA2 and Pus1UIM respectively, Fig. 2B), we
could show that the UBA domains of Rhp23 and the UIM
domain of Pus1 were su⁄cient to protect the tetraubiquitin
chains against deubiquitination by UBPY and were as e⁄cient
as the full length proteins (Fig. 2). Each of the two UBA
domains of Rhp23 is able to bind multiubiquitin [10], and
both appear about equally e⁄cient in inhibiting deubiquitina-
tion (Fig. 2A, lanes 5 and 6).
The inhibitory proteins had no direct e¡ect on the activity
of the deubiquitinating enzyme: the UBPY enzyme cleaved
the £uorogenic substrate ubiquitin-AMC and was inhibited
by Ubal (Fig. 3). However, no signi¢cant e¡ects were ob-
served when Rhp23, Dph1 or Pus1 were added in equimolar
amounts with the substrate (Fig. 3) or even at concentrations
50 times higher (not shown).
Conceivably Rhp23, Dph1 or Pus1 might inhibit deubiqui-
tination by binding UBPY. However, in precipitation experi-
ments we could not detect any such interactions (not shown).
Next we sought to test whether our previous data could be
reproduced in ¢ssion yeast extracts. Cell extracts from the
proteasome mutant mts3-1 [22] strain grown at the restrictive
temperature contain high molecular weight ubiquitin^protein
conjugates (Fig. 4, lane 1). The ubiquitin conjugates disap-
peared upon incubation (Fig. 4, lane 2) because of intrinsic
deubiquitinating enzymes in the cell extract. The alternative
explanation, that the conjugates were degraded by 26S pro-
teasomes, can be ruled out because proteasomes from the
mts3-1 mutant are inert at the temperature used here [27]
and the extract contained proteasome inhibitor as a further
precaution. Con¢rming our previous results, addition of
Rhp23 and Dph1 stabilised the ubiquitin conjugates (Fig. 4,
lanes 3 and 4), as did N-ethylmaleimide (NEM), a potent
inhibitor of most deubiquitinating enzymes (Fig. 4, lane 6).
However, again the e¡ect of Pus1 was not as strong (lane 5).
4. Discussion
In order to be degraded by the 26S proteasome proteins
must carry ubiquitin chains composed of at least four ubiq-
uitin moieties [7]. When the proteasome degrades the multi-
ubiquitin-tagged substrate, the ubiquitin chains become de-
tached. Several isopeptidases or ubiquitin-speci¢c proteases
Fig. 3. Ubiquitin-AMC hydrolysis is not inhibited. Hydrolysis of
the ubiquitin-AMC substrate by the ubiquitin-speci¢c protease
UBPY in the presence or absence of the ubiquitin binding proteins
Rhp23, Dph1, Pus1 and the inhibitor Ubal. The data are shown as
averagesS S.E.M., n=5. In the presence of Ubal the hydrolysis was
inhibited (***P6 0.001, Student’s t-test), whereas the ubiquitin
binding proteins had no signi¢cant e¡ects.
Fig. 4. Inhibition of ubiquitin chain disassembly in extracts. In the
presence of proteasome inhibitor high molecular weight ubiquitin
conjugates in the mts3-1 mutant (lane 1) become disassembled by
intrinsic ubiquitin-speci¢c proteases during 3 h incubation at 37 ‡C
(lane 2). Disassembly is retarded by Rhp23 (lane 3), Dph1 (lane 4)
and less so by Pus1 (lane 5). In the presence of NEM deubiquitina-
tion is inhibited (lane 6).
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associated with 19S particle of the 26S proteasome presum-
ably mediate this deubiquitination and protein degradation
and multiubiquitin release seems to be tightly coupled [28^34].
The budding yeast genome encodes at least 17 di¡erent
deubiquitinating enzymes and higher eukaryotes contain sev-
eral more [35]. Some of the deubiquitinating enzymes trim
ubiquitin chains sequentially from the distal end [28]. This
ubiquitin chain editing process potentially regulates the sub-
strate’s association time with the 26S proteasome and could
spare substrates from degradation if the ubiquitin chains be-
come so short that they lose a⁄nity for the proteasome (dis-
cussed in [36]).
Genetic and biochemical evidence shows that three ubiqui-
tin binding proteins, Rhp23, Dph1 and Pus1, help target ubiq-
uitinated proteins to the 26S proteasome [10]. These proteins
all preferentially bind ubiquitin chains of four or more ubiq-
uitin moieties, and their combined deletion results in the ac-
cumulation of multiubiquitin conjugates and is lethal in ¢s-
sion yeast [10]. Moreover, experiments have shown that when
Rad23 and Dsk2, the Rhp23 and Dph1 orthologues in bud-
ding yeast, are overexpressed, some proteins are stabilised and
multiubiquitin conjugates accumulate [17,23^26]. Since this
e¡ect is independent of whether the proteins interact with
26S proteasomes [17] it is hardly due to inhibition of protea-
somes. The stabilisation of proteins may instead be caused by
shifting of an equilibrium so that a larger proportion of the
ubiquitin conjugates remain bound to Rhp23, Dph1 and Pus1
rather than being transferred to the proteasomes. The accu-
mulation of multiubiquitin conjugates might also be caused by
an inhibition of deubiquitination and our results did indeed
show that Rhp23, Dph1 and Pus1 inhibit deubiquitination,
both by the mammalian enzyme UBPY and by deubiquitinat-
ing enzymes in yeast extracts. The e¡ect was found both with
tetraubiquitin and with natural ubiquitinated substrates. The
inhibition was due to the ubiquitin binding capacity of the
proteins and the ubiquitin binding domains alone were su⁄-
cient to protect substrate proteins against deubiquitination.
However, Rhp23 and Dph1 appeared to inhibit deubiquitina-
tion much more strongly than Pus1 did.
Both Rhp23 and Dph1 bind ubiquitin chains via an V80
amino acid UBA domain, whereas Pus1 binds via a smaller
V20 amino acid UIM domain. Perhaps due to a steric block-
age of the deubiquitinating enzyme the bulky UBA domain in
Rhp23 and Dph1 is better suited for inhibition than the small-
er UIM domain in Pus1.
Rhp23, Dph1 and Pus1 did not signi¢cantly inhibit deubiq-
uitination of ubiquitin-AMC, presumably because they only
have very weak a⁄nity for monoubiquitin [10], and therefore
also for the ubiquitin-AMC substrate.
Rhp23, Dph1 and Pus1 have been shown to have important
functions in the regulation of protein degradation [10], but the
biochemical mechanisms which regulate their function remain
to be unravelled. The ubiquitination status of a given protein
is determined by the balance between ubiquitination and deg-
radation on one hand and deubiquitination on the other. By
protecting substrates against deubiquitination, Rhp23, Dph1
and Pus1 may favour degradation rather than deubiquitina-
tion, by pushing the equilibrium between degradation and
deubiquitination towards degradation. This is a function
which only depends on the ability to interact with ubiquitin
chains and is therefore likely to be shared by most if not all
multiubiquitin binding proteins.
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